Advances in the Treatment of Multiple Myeloma

PROGRAM DESCRIPTION This webcast is intended to improve care of patients with multiple myeloma (MM) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents ...

PROGRAM DESCRIPTION
This webcast is intended to improve care of patients with multiple myeloma (MM) by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

EDUCATIONAL OBJECTIVES
As a result of participating in the activity, learners should be better able to: Identify the shift from palliative 2-drug combinations towards the use of modern, potent, 3- or 4-drug combination regimens in patients with newly diagnosed and smoldering MMAssess the selection and sequencing of 3- or 4-drug combination novel regimens for risk stratified patients with MMCustomize the selection, sequencing of drug combination novel therapies for patients with relapsed/refractory MM

---

Write the first review

Resource tags